Not a good thing to be on the non covered list by private health insurance carriers. It will be an uphill stuggle to get commercial coverage for this product. Lot's of competition in the field. It has a non specific HCSPCS code which insurors don't like to deal with at all. Last I checked McKesson was not carrying the product for purchasing by outpatient clinics.
Generex seems to have put their eggs in the VA system basket. Let's hope they succeed in hatching them in 2020. Is all that on hold until they get the S-1 ok by the SEC and get funded?
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links